TrialScientific reports2018

Discordance in glycemic categories and regression to normality at baseline in 10,000 people in a Type 2 diabetes prevention trial.

Mike Sampson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.